NCT05162443 2025-08-26Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C MutationBristol-Myers SquibbApproved for marketing
NCT00338247 2016-04-06EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNovartisApproved for marketing